TRPV1-target drugs for the treatment of orofacial pain

Orofacial pain, encompassing sensory and emotional discomfort in the facial and oral regions, is a multifaceted condition that significantly impacts patients’ quality of life. This review focuses on the role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in modulating orofacial pain an...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Cláudia Macedo Andrade, Natalia Molina Esquivel, Florencia Goldschmied Rossel, Bruna Benso
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1568109/full
Tags: Add Tag
No Tags, Be the first to tag this record!